Haoxi Health Technology Limited - Class A Ord Share: stock overview

HAONASDAQCommunication services · Services-Advertising Agencies

Price

$2.08

November 13, 2026

DCF calculator

What Ploutos Investor adds for Haoxi Health Technology Limited - Class A Ord Share

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 5 fiscal years, from FY2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.

In short

Haoxi Health Technology Limited - Class A Ord Share had revenue of $55M in the fiscal year to June 30, 2026 and a net loss of $9.5M. Revenue grew by 35.7% a year on average over the last 4 years. It holds more cash than debt, by $9.6M. It pays no dividend.

From its SEC filings (latest fiscal year to June 30, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
–
24.7K shares
P/E
–
Revenue, fiscal year
$55M
+35.7% a year over 4 years
Net margin
-17.4%
FY2025: 11.8%, above 75% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+6.3% a year over 2 years

  • FY2026Jun 30, 202620-F
    Revenue$55M
  • FY2025Jun 30, 202520-F
    Revenue$33M
  • FY2024Jun 30, 202420-F
    Revenue$49M

Fiscal years in figures

HAO's revenue, profit, cash flow and dividend with each year-end price, from FY2022 to FY2023, 2 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Sorry, we do not have enough data

for the “Valuation” group

Profitability

Gross margin 
1.2%
Operating margin 
-17.6%
Net margin 3-year median: 2.7%
-17.4%
ROIC 
-42.1%
ROIC, 5-year average 
2.8%
ROE, fiscal year 
-53.4%

Growth

Revenue, yearly change 
+67.1%
EPS, yearly change 
-111.4%
FCF, yearly change 
–
Revenue, average a year 
+35.7%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$11M
Total debt 
$1.3M
Net cash 
$9.6M
Net debt / EBITDA 
–
Interest cover 
-184.3x
Current ratio 
–

Balance sheet of June 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+2,606.1%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 73).

Gross margin

2.8%

Above 1% of the 293 companies in its industry, and 3% of all.

Operating margin

-6.1%

Above 28% of the 462 companies in its industry, and 24% of all.

Net margin

11.8%

Above 75% of the 473 companies in its industry, and 69% of all.

Revenue growth

-32.4%

Above 1% of the 461 companies in its industry, and 2% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Haoxi Health Technology Ltd
CIK
1954594
Exchange
NASDAQ
Industry (SIC)
7311 · Services-Advertising Agencies
Fiscal year ends
June 30
Latest annual report
June 30, 2026
Reporting currency
USD
Shares
24.7K

Other companies: Communication services

The largest companies of the same sector, each with its own page.

The Communication services sectorAll companies

The full analysis

What do Haoxi Health Technology Limited - Class A Ord Share's filings show?

These are Haoxi Health Technology Limited - Class A Ord Share's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about HAO

Didn't find what you were looking for?

Ask us
How much revenue does HAO have?

Haoxi Health Technology Limited - Class A Ord Share had revenue of $55M in the fiscal year to June 30, 2026. Over the last 4 years it changed by +35.7% a year on average.

Does HAO pay a dividend?

No. Haoxi Health Technology Limited - Class A Ord Share paid no regular dividend over the last 12 months.

Where do the figures come from?

From Haoxi Health Technology Limited - Class A Ord Share's SEC filings (its annual report on 20-F) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.